Crossmark

Real-World Glycemic Lowering Effectiveness of Linagliptin Among Adults with Type 2 Diabetes by Age, Renal Function, and Race

Published Online: 2020-05-27

Published Print: 2020-07

Authors

Hoogwerf, Byron J.

MacKenzie, Michele

Sealls, Whitney

Cordova, Jeanine

Gandhi, Pranav
Funding

Funding for this research was provided by:

Boehringer Ingelheim
License Information

Text and Data Mining valid from 2020-05-27

Version of Record valid from 2020-05-27
More Information

Article History

Received: 15 April 2020

First Online: 27 May 2020

Document is current